tiprankstipranks
Blurbs

Analysts Have Conflicting Sentiments on These Healthcare Companies: Grifols SA (GRFS), Tecan Group AG (OtherTCHBF) and Calliditas Therapeutics (CALT)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Grifols SA (GRFSResearch Report), Tecan Group AG (TCHBFResearch Report) and Calliditas Therapeutics (CALTResearch Report).

Grifols SA (GRFS)

In a report issued on June 16, Dariusz Ubik from Kepler Capital maintained a Hold rating on Grifols SA, with a price target of EUR22.90. The company’s shares closed last Friday at $11.57.

According to TipRanks.com, Ubik is ranked #6109 out of 7890 analysts.

Currently, the analyst consensus on Grifols SA is a Hold with an average price target of $24.13.

See today’s best-performing stocks on TipRanks >>

Tecan Group AG (TCHBF)

In a report issued on June 16, Maja Pataki from Kepler Capital maintained a Buy rating on Tecan Group AG, with a price target of CHF384.00. The company’s shares closed last Friday at $315.00, close to its 52-week low of $308.81.

According to TipRanks.com, Pataki is ranked #7742 out of 7890 analysts.

Currently, the analyst consensus on Tecan Group AG is a Strong Buy with an average price target of $481.76, a 65.4% upside from current levels. In a report issued on June 6, UBS also maintained a Buy rating on the stock with a CHF536.00 price target.

Calliditas Therapeutics (CALT)

Kepler Capital analyst Jon Berggren maintained a Buy rating on Calliditas Therapeutics on June 16 and set a price target of SEK140.00. The company’s shares closed last Friday at $17.70.

According to TipRanks.com, Berggren is ranked #7251 out of 7890 analysts.

Calliditas Therapeutics has an analyst consensus of Moderate Buy, with a price target consensus of $29.54.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on GRFS:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles